FDA.reportPublic FDA data

AMIVANTAMAB - Food and Drug Administration

Manufacturer
Food and Drug Administration
Effective date
2026-01-27
Label type
Indexing - product concept
Version
1
Source
full-release
Hydrated at
2026-06-05 00:26:48

Label at a glance#

ProductAMIVANTAMAB
Active ingredientAMIVANTAMAB, HYALURONIDASE (HUMAN RECOMBINANT)

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
AMIVANTAMAB0JSR7Z0NB6ACTIB
HYALURONIDASE (HUMAN RECOMBINANT)743QUY4VD8ACTIB

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.